The reporter learned from the China Technology Center of Shanghai Air Products Company in Shanghai on March 22 that the newly expanded technology center will complement the technical centers of Japan, South Korea, and Taiwan in China to support the rapid growth of Asian business development. . According to the latest statistics from the Ministry of Commerce, at present, the number of multinational companies that have set up R&D centers in China is close to 1,000. Among them, pharmaceuticals, chemical raw materials, chemicals, and new materials are the most intensive industries for foreign companies' R&D centers in China.
The reporter learned that many multinational chemical companies are busy building and expanding their R&D centers in China. These R&D centers are mainly distributed in locations where foreign investment is concentrated in Shanghai, Shenzhen, and Beijing. BASF, Bayer, DuPont, GE, Ciba, and Dow Corning have established R&D centers in China. R&D investment is also accelerating. Degussa is currently expanding its R&D center in Shanghai and is expected to complete it by mid-year. Up to now, Degussa's investment in the R&D center has exceeded 20 million euros. Novozymes is the world's largest enzyme company. Only 20% of Novozymes' China R&D department in Beijing is responsible for the direct development of the Chinese market, while the other 80% are international projects. Not long ago, Novozymes' global textile laboratories also moved from the United States to China, and the biomass fuel laboratory in cooperation with COFCO has just been completed. LANXESS's R&D center in Wuxi not only independently developed more than 100 new varieties of leather chemicals and textile auxiliaries adapted to the needs of domestic and foreign markets, but also reached international synchronization levels. LANXESS Wuxi has become the largest R&D center outside the headquarters of LANXESS. Its radiation surface and influence have been extended to the entire Asia-Pacific region.
According to statistics of the World Bank, independent and non-independent R&D institutions set up by multinational corporations in China rank among the top in the developing world. And five years ago, there were no more than 200 such institutions. At present, the strategy pursued by such institutions is talent localization. In other words, the main force supporting these R&D centers is a large number of scientific and technological personnel in China. Insightful people reminded us that a few years ago, China was only the manufacturing center of the world, and multinational companies had mastered the hands of the Chinese. Now that multinational corporations have begun to build the image of China’s R&D center, it is actually necessary to grasp the creativity of the Chinese people. This shows that multinational companies have more and more in-depth control of the core of the Chinese market.
The reporter learned that many multinational chemical companies are busy building and expanding their R&D centers in China. These R&D centers are mainly distributed in locations where foreign investment is concentrated in Shanghai, Shenzhen, and Beijing. BASF, Bayer, DuPont, GE, Ciba, and Dow Corning have established R&D centers in China. R&D investment is also accelerating. Degussa is currently expanding its R&D center in Shanghai and is expected to complete it by mid-year. Up to now, Degussa's investment in the R&D center has exceeded 20 million euros. Novozymes is the world's largest enzyme company. Only 20% of Novozymes' China R&D department in Beijing is responsible for the direct development of the Chinese market, while the other 80% are international projects. Not long ago, Novozymes' global textile laboratories also moved from the United States to China, and the biomass fuel laboratory in cooperation with COFCO has just been completed. LANXESS's R&D center in Wuxi not only independently developed more than 100 new varieties of leather chemicals and textile auxiliaries adapted to the needs of domestic and foreign markets, but also reached international synchronization levels. LANXESS Wuxi has become the largest R&D center outside the headquarters of LANXESS. Its radiation surface and influence have been extended to the entire Asia-Pacific region.
According to statistics of the World Bank, independent and non-independent R&D institutions set up by multinational corporations in China rank among the top in the developing world. And five years ago, there were no more than 200 such institutions. At present, the strategy pursued by such institutions is talent localization. In other words, the main force supporting these R&D centers is a large number of scientific and technological personnel in China. Insightful people reminded us that a few years ago, China was only the manufacturing center of the world, and multinational companies had mastered the hands of the Chinese. Now that multinational corporations have begun to build the image of China’s R&D center, it is actually necessary to grasp the creativity of the Chinese people. This shows that multinational companies have more and more in-depth control of the core of the Chinese market.
Drop plastic product it is soft, the product of injection molding is relatively hard many, drop plastic is to do not hard you a comparison to know.
Droplet is a process used to make the surface of a printed matter a crystalline process
Decorative effect, as well as water resistance, moisture resistance and light resistance
It is applied to household appliances, advanced automobiles, trademark nameplates, commemorative MEDALS, handicrafts and so on
Injection Molding Drop Plastic Type
Custom Injection Molding Type,Low Cost Injection Molding,Injection Mold Designer,Plastic Components
Shenzhen Baoan District Shai Cheng Zhi Bin Hardware Products Factory , http://www.sz-cthj.com